Ascentage Pharma Group International (ASPHF) Financials

ASPHF Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 566.8 million 376.0 million
June 30, 2025 425.2 million 330.8 million
Dec. 31, 2024 358.6 million 321.1 million
June 30, 2024 427.6 million 320.7 million

ASPHF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 ? ?
June 30, 2025 -63.1 million 1.8 million
Dec. 31, 2024 32.2 million 1.7 million
June 30, 2024 -51.0 million 1.2 million

ASPHF Net Income

No data available :(

ASPHF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 353.2 million 106.2 million 2.1 million
June 30, 2025 231.9 million 121.0 million 3.7 million
Dec. 31, 2024 169.4 million 119.0 million 4.1 million
June 30, 2024 151.4 million 132.0 million 2.9 million

ASPHF Shares Outstanding

No data available :(

ASPHF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - 84.1 million 45.7 million -
June 30, 2025 2.8 million 73.8 million 33.1 million 19.2 million
Dec. 31, 2024 1.1 million 68.9 million 28.3 million 14.6 million
June 30, 2024 2.3 million 61.1 million 24.3 million 12.3 million

ASPHF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 47.8 million 9.8 million
June 30, 2025 4.5 million 3.0 million
Dec. 31, 2024 21.5 million 1.9 million
June 30, 2024 113.4 million 2.1 million

ASPHF

Price: $4.53

52 week price:
4.53
10.65

Earnings Per Share: -0.53 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.8 billion

Links: